Objective. Interventional pain management procedures have an important role in the management of chronic pain. The present study seeks to identify the proportion of patients who experience severe pain during pain procedures either with or without sedation. There is then an attempt to identify any association of high pain levels with factors such as age, gender, ethnicity, preprocedure pain level, procedure type, tobacco use, and baseline pharmaceuticals taken for both pain and/or mood disorder management.
Introduction
Interventional pain management procedures (IPMP) have become an integral component in the comprehensive approach for the management of intractable chronic pain. IPMP are conducted in a variety of clinical settings, which include physicians' offices, hospital procedural suites, ambulatory surgery centers, and operating rooms. There are pain practitioners of both anesthesia and nonanesthesia currently performing interventional techniques. There is, however, little insight as to how comfortable chronic pain patients are during these procedures.
Furthermore, there is no approach put forth to identify patients prior to IPMP who may be at risk for increased levels of pain. The injection of local anesthetic, lidocaine, is anecdotally regarded as the most painful aspect of IPMP. The response to local anesthetic injection has been suggested at least in one study to predict pain sensitivity [1] . Indeed, higher pain scores after subcutaneous lidocaine injection correlate with increased anxiety and body movement during needle placement [1] . High levels of pain during lidocaine infiltration have a weak correlation to negative short-term outcomes with lumbar epidural steroid injections to treat painful lumbosacral radiculopathy [2] . Practically, the determination of pain levels after the injection of local anesthetic does not help the clinician plan ahead so as to ensure patient comfort.
In general, the use of deep sedation to mitigate patient discomfort especially in an indiscriminate fashion has been discouraged [3] . The loss of the ability of a patient to report increased pain and paresthesias, especially during cervical IPMP, may predispose to significant neurological injury [4] . Not surprising, intravenous (IV) sedation use varies widely across the United States, with a mean of 64% across all IPMP [5] . Previous studies identified anxiety as a key factor driving oral sedation requests in 28% to 58% of patients undergoing spinal injections and recommended against the routine use of sedation [6, 7] . While anxiety reduces pain tolerance, direct assessment of pain was not performed in either study.
Recognizing the observational fact that some patients can experience severe pain during IPMP despite local anesthetic infiltration, there is a need to explore factors that might help to identify these individuals. The primary aim of the present study was to prospectively determine procedure-related discomfort as rated by both the patient and physician proceduralist. A subgroup analysis in patients who experience high levels of pain was then performed to determine if any correlation exists with known clinical characteristics.
Methods

Study Design and Patient Selection
This is a prospective survey evaluation of pain during IPMP in a tertiary care center outpatient procedural facility. The proceduralist and the patient filled out survey forms for determining procedure-related pain in the absence of sedation. In cases of conscious sedation, an additional form was completed by the nurse administering the sedatives midazolam and fentanyl. The exclusion criterion for the study was insufficient understanding of the English language to complete the survey form.
Data Collection
All patients enrolled in the survey had the following baseline demographic data including age, gender, ethnicity, preprocedure pain level, procedure type, and tobacco use. In addition, the relevant medications that include antidepressants, membrane-stabilizing agents, benzodiazepines, skeletal muscle relaxants, and morphine equivalent dose of opioids consumed (three months of opioid use or greater) were recorded. The survey form used was the PROcedural Sedation Assessment Survey (PROSAS) (Appendix) [8] . The PROSAS is a clinically relevant, patient-centered questionnaire that specifically addresses periprocedural discomfort. Specifically, The PROSAS includes pre-intraand postprocedure questions of pain severity completed by patients. This questionnaire also inquires on the adequacy of sedation. The PROSAS also includes intraprocedural pain assessment from both the physician performing the procedure and the nurse administering the sedation. PROSAS rates patient comfort on a 0 (no pain) to 10 (severe pain) scale and satisfaction with sedation level on -5 (markedly less sedation then wanted) to þ5 (markedly more sedation then wanted) scale. Physicians, procedural and recovery area nurses were also asked to complete a brief survey addressing the quality of sedation and assessment of patient discomfort. Procedural nurses reported sedation events, which were defined as any case with one or more of the following: 1) any episodes of oxygen desaturation of less than 90% or leading to intervention, 2) any problematic changes in heart rate or blood pressure during intervention (systolic blood pressure < 90 or >160; heart rate <50 or >120), 3) any hemodynamic or respiratory conditions that interrupted the procedure, 4) use of opioids or benzodiazepine reversal agents, 5) hospitalization because of an adverse event of sedation. All sedation-related adverse events were recorded at the time of the procedure. In addition, procedural and recovery nurses ranked patient level of sedation on a -5 (markedly undersedated) to 5 (markedly oversedated) scale and patient discomfort on a 0 (none) to 10 (procedure aborted due to severe patient discomfort) scale. Sedation was administered to patients upon request or in those who had significant pain with IPMP in the past.
For patients not receiving sedation, the PROSAS was altered for relevancy. For nonsedation patients, there was no procedure nurse, so that form was omitted, and the postprocedure physician and recovery nurse items directly related to sedation were removed; in the patient postprocedure form, for the question asking "If having this procedure again in the future, how much sedation would you prefer to have?" the response scale was changed from "markedly less sedation" to "markedly more sedation" to "none" to "asleep/heavily sedated." There were no other differences in methodology between the sedated and nonsedated cohorts. Patient discomfort scales used in sedated and nonsedated patients were identical.
Data Analysis
Primary analysis was qualitative. For evaluation of predictors of sedation quality, the Student's t test and Fishers exact test were used for continuous and categorical variables, respectively. Spearman's Rho was used for correlation of linear data. Additionally, binary logistic regression was used to evaluate clinical factors independently related to risk of poor sedation quality. Statistical analysis was completed using SPSS for Windows (Rel. 19.0 2011; SPSS, Inc., Chicago, IL, USA). All authors had access to the study data and reviewed and approved the final manuscript. 
Results
There were 155 patients evaluated for procedure-related pain with predominantly white ethnicity and an average age of 57 years, most often undergoing spinal injections (Table 1) . Mean preprocedure discomfort level was 6.5 (range ¼ 0-10) ( Table 2 ). Mean patient-reported procedural pain intensity level was 3.5 (range ¼ 0-10). The mean physician-rated procedure-related pain was slightly lower at a mean of 2.1 (range ¼ 0-8) (P ¼ 0.002). The mean postprocedure pain level reported was 3.7 (range ¼ 0-10). There was no association of age, gender, or ethnicity with procedure-related pain. Nearly 43% of patients received opioids, with the majority on less than 50 mg morphine equivalents per day (MED). A significant proportion of patients received antidepressants (39.4%) and membrane-stabilizing agents (45.2%), with significantly less use of benzodiazepines (20.7%) and muscle relaxants (11.0%). There was a lack of procedural discomfort predictive value for any of these classes of medications including opioids. Active tobacco use (14.1%) also did not predict patientreported procedural pain (P ¼ 0.192). Lastly, no single intervention was determined to cause more procedural pain than another. Table 3 lists the distribution of spinal interventions that were performed primarily in a nonsedated fashion. An average of 14.2% of patients experienced severe pain during the procedure. Only 10 patients received sedation in the form of midazolam, mean dose of 2.4 mg (range ¼ 1-4 mg), and fentanyl, mean dose of 125 mcg (range ¼ 50-200 mcg), with the majority (60%) still rating procedure-related pain as severe. None experienced adverse hemodynamic or respiratory adverse events. In addition, none of the patients undergoing nonspinal injections (Table 4) received sedation, representing the minority of overall injections. Up to 20% of these patients reported severe pain during the procedure, but this value was not statistically different from nonspinal (P ¼ 0.504).
There is a strong correlation between physician-and patient-reported procedural discomfort (P < 0.001) ( Table 5) . Specifically, physicians best appreciated when a procedure did not seem to produce much discomfort. The ability to detect significant procedural pain by the physician was with a low kappa value (0.286), however, with physicians underestimating procedural discomfort.
Discussion
The present study supports the current practice that the majority of patients tolerate routine IPMP procedures with local anesthetic infiltration only and do not experience severe pain. The data heavily reflect IPMP of the spine, but nonspinal IPMP seem to follow a similar trajectory. Thus the present data do not lend sustenance to the routine use of sedation for IPMP and would call for conservation of sedation services. When a patient does experience significant pain, it is common for the treating physician to underestimate this negative experience. Therefore, there was an attempt to determine if factors such as age, gender, ethnicity, smoking habits, preprocedure pain level, or medication classes (opioids, benzodiazepines, antidepressants, anti-epileptics, and skeletal muscle relaxants) may help identify this [1, 9, 10] . Active or prior tobacco use has been reported to be associated with greater pain intensity than never smokers, but no pattern was found in the present study [11, 12] .
There is inconsistency in the literature on the predictive value of chronic opioid therapy on pain levels following noxious stimuli, in particular subcutaneous lidocaine injections. Cohen et al. found higher levels of pain response, suggesting hyperalgesia in such patients, whereas Manabat et al. did not find any correlation [13, 1] . Similarly, our study failed to demonstrate a correlation of discomfort and opioid use, but in both cases this may reflect lower daily doses of opioid medication (<50 MED), similar to Manabat et al. Wasan et al. [14] determined that hyperalgesic response during quantitative sensory testing was not predicted by opioid dose but correlated to pain-related distress (anxiety and catastrophizing) as well as high risk for opioid misuse. They concluded that these high-risk patients as determined by the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R) have consistently higher pain sensitivity independent of opioid dose. Risk stratification by SOAPP-R was not given to patients in this study to permit a similar analysis.
Anxiety levels were not assessed in the present study but have been shown in prior studies to correlate with pain intensity [1, 14] . Using the presence of a mood-stabilizing medication as a surrogate does not seem to work in the present study and may reflect the actual improvement rendered by these medications. A survey study on patients not routinely offered sedation undergoing primarily spinal injections demonstrated that only 17% requested procedural sedation for the first injection [6] . This number rose to 28% upon the need to perform a second intervention. Patients requesting sedation before proceeding with an injection were found to have higher anxiety levels, but the main reason for the request for sedation on the second intervention was procedural pain. A follow-up study by the same group liberally offered patients the choice of sedation prior to spinal injections and found that 58% of patients preferred sedation [7] . There was again significant correlation of sedation requests to anxiety levels but no measure of the impact of anxiety control on procedure-related pain. There is a strong suggestion that simply controlling anxiety would reduce procedure-related pain, but the full effectiveness of such a strategy needs further investigation [15] .
Minimizing pain during IPMP can be thought of in terms of the procedural technique and methods of sedation. The prevalence of neuropathic pain as determined by neuropathic pain scales can result in hyperalgesia, particularly in chronic spinal conditions [16] . The resulting increased pain sensitivity can make ensuring procedural comfort challenging. Neuropathic scales were not administered during the present study that could potentially help identify those who may experience higher levels of pain. The painful attributes of a spinal injection include several phases of the procedure: 1) initial needle insertion and injection of local anesthetic (phase I), 2) manipulation and repositioning of the needle in deep tissue (phase II), and 3) injection of therapeutic medication (phase III, e.g., targeting an inflamed nerve root or synovial joint). In the literature, at least one study suggests that phase I has a strong association with overall postprocedure pain scores due to the initial noxious stimulation [17] . Both use of topical anesthetic cream (5% liposomal lidocaine) [18] and initial injection of local anesthetic into deeper subcutaneous tissues with minimal skin wheal [17] can help reduce phase I-related pain. Reducing the needle gauge from 22 to 25 may help further reduce phase II pain [17] . It is not clear if additional injection of local anesthetic prior to advancing the needle to deeper levels would enhance procedural comfort. There have been no studies on the optimal local anesthetic type or concentration for IPMP. Studies in other disciplines have suggested minimizing pain on local anesthetic injection by inserting the smallest appropriate gauge needle in a perpendicular manner and injecting bicarbonate buffered warmed lidocaine solution slowly [18] [19] [20] [21] . Additional limitations of the current study are that it was not designed to address the impact of needle gauge, technique, or operator experience on patient comfort during IPMP. It is also possible that there exist differences among approaches to the epidural space (e.g., caudal vs interlaminar). The degree to which these modifications, as well as not addressing phase III, impact pain during IPMP requires further research.
Sedation seems to be the most logical approach to ensure patient comfort and reduce anxiety levels during IPMP. There is certainly good support for the use of sedation for painful minimally invasive procedures, and this technique is commonly used in up to 90% of IPMP involving discograms and implantable therapies [22, 5] . While the current study could not identify risk factors for significant procedural pain, anxiety measures or even the SOAPP-R may help isolate candidates. Although the current study had only 10 patients receiving conscious sedation, most did continue to experience severe pain, which is consistent with prior experiences with conscious sedation for spinal injections as well as other procedures such as colonoscopy [17, 8] . These observations suggest that usual doses of fentanyl and midazolam or the agents themselves fall short of enhancing procedural comfort. Patients who receive sedation for IPMP may have high baseline anxiety and/or have the expectation of a relatively pain-free procedure, leading to a negative experience once such expectations are not met. The routine application of deeper sedation for IPMP is also not a clear option and has not been recommended on account of safety concerns [3] . Thus, there remains a knowledge gap as to which agents, and in what doses, can minimize pain while maintaining a safe level of consciousness.
Conclusions
The current study demonstrates that the majority of patients undergoing IPMP do not experience severe pain. A small but significant percentage of subjects experience significant procedural discomfort but cannot be risk-stratified by any clinical characteristics identified on standard clinical assessment or by the treating physician. Finally, it remains unclear if conscious sedation in the usual doses of fentanyl and midazolam ensures adequate patient comfort during IPMP. During IPMP, physicians can easily identify comfortable patients but underestimate the severity of pain in those individuals who experience significant discomfort. Please fold survey upon completion. Also, please note that in the case of double procedures, this survey is for overall comfort level.
Procedure observations:
Any episodes of O2 desaturation < 90% or leading to intervention? How much discomfort did the patient experience during the procedure?
Please rate the patient's cooperation during the procedure:
h Procedure aborted due to lack of cooperation h Procedure delayed/interrupted due to lack of cooperation h Adequately cooperative Physician (name):
Other physician present:
Please fold survey upon completion. Also, please note that in the case of double procedures, this survey is for overall comfort level.
During the procedure:
What level of sedation best describes the case overall?
Examples of level of sedation Place label here
How much discomfort did the patient experience during the procedure?
h Procedure aborted due to lack of cooperation h Procedure delayed/interrupted due to lack of cooperation h Adequately cooperative
Was the exam interrupted in any way due to patient discomfort?
h Yes *We define a patient with optimal recovery as one who is comfortable and without nausea in recovery and who is awake and ready to be discharged within 20-30 minutes postprocedure.
Did the patient complain of any pain during recovery? h Postal mail (The nurse will give you a short survey in a prestamped envelope to be completed within 48 hours of your procedure)
